Despite nervous investors and a volatile market, a courageous few biotechnology companies are taking their chances on Wall Street.
Despite nervous investors and a volatile market, a courageous few biotechnology companies are taking their chances on Wall Street.
How to successfully surmount the challenges women face in becoming biotech industry leaders
Despite the down economy, universities are ramping up their efforts to commercialize their research.
The surprising results when drug development and altruism collide
Despite chill winds on Wall Street, investors continue to place bets on fledgling biotechnology companies.
Page 1 of 1